What Are the Regulatory and Sourcing Requirements for Safe Peptide Therapy in China?
Ensuring safe peptide therapy in China requires navigating NMPA's rigorous biologic classification, MAH system, clinical trial mandates, and strict GMP adherence.
HRTioJuly 21, 2025